Loading clinical trials...
Loading clinical trials...
This study tests whether denileukin diftitox will deplete regulatory T cells, boost tumor-specific immunity and treat epithelial ovarian cancer in patients who have failed, or who are ineligible for f...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
The University of Texas Health Science Center at San Antonio
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT06915025 · Epithelial Ovarian Cancer, Ovarian Cancer, and more
NCT06710548 · Ovarian Cancer, Advanced Ovarian Carcinoma, and more
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT06290193 · Ovarian Cancer, Fallopian Tube Carcinoma, and more
CTRC at UTHSCSA
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions